Trinity Biotech Files Routine 6-K Report
Ticker: TRIB · Form: 6-K · Filed: Sep 23, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Sep 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1,013,706, $0.0109 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, routine-report
TL;DR
Trinity Biotech filed its monthly 6-K, just a standard update, no big news.
AI Summary
Trinity Biotech plc filed a Form 6-K on September 23, 2024, to report its activities for the month of September 2024. The company, based in Ireland, is a foreign private issuer and is required to file this report under the Securities Exchange Act of 1934. This filing does not appear to contain specific financial figures or operational updates beyond its routine reporting nature.
Why It Matters
This filing serves as a routine update for investors and regulators, confirming the company's ongoing compliance and reporting obligations as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine, periodic report and does not contain new material information that would typically impact risk.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- Securities Exchange Act of 1934 (legal_document) — Governing regulation
- September 2024 (date) — Reporting period
- 20240923 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically for reporting information made or intended to be made public in a foreign country, filed with or distributed to its security holders, or filed with a stock exchange on which its securities are traded.
What period does this specific Form 6-K cover?
This Form 6-K report covers the month of September 2024.
Is Trinity Biotech plc a US-based company?
No, Trinity Biotech plc is identified as a foreign private issuer with its principal executive office located in Bray, County Wicklow, Ireland.
Does Trinity Biotech file annual reports on Form 20-F or 40-F?
Yes, the filing indicates that Trinity Biotech plc files annual reports under cover of Form 20-F.
What is the SIC code for Trinity Biotech plc?
The Standard Industrial Classification (SIC) code for Trinity Biotech plc is 2835, which pertains to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Stats: 394 words · 2 min read · ~1 pages · Grade level 12.9 · Accepted 2024-09-23 08:11:34
Key Financial Figures
- $1,013,706 — he Company may sell up to an additional $1,013,706 of American Depositary Shares ("ADSs"),
- $0.0109 — Company's A Ordinary Shares, par value $0.0109 per share, from time to time, through C
Filing Documents
- zk2432055.htm (6-K) — 15KB
- exhibit_5-1.htm (EX-5.1) — 75KB
- image0.jpg (GRAPHIC) — 57KB
- image00003.jpg (GRAPHIC) — 8KB
- image00004.jpg (GRAPHIC) — 25KB
- 0001178913-24-003121.txt ( ) — 214KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/Louise Tallon Louise Tallon Chief Financial Officer Date: September 23, 2024